DLX5 and colorectal carcinoma: These results indicated the high expression of DLX5 in CRC and its positive correlation with lncRNA RP11-197K6.1, thus suggesting that DLX5 may promote CRC development by participating in specific biological signaling pathways and forming a mutual regulatory network with lncRNA RP11-197K6.1, thereby collectively influencing the progression and prognosis of CRC.